Simplex Trading’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-564
| Closed | -$1.01M | – | 8968 |
|
|
2020
Q2 | $1.01M | Sell |
564
-178
| -24% | -$2.48K | ﹤0.01% | 2144 |
|
|
2020
Q1 | $529K | Sell |
742
-131
| -15% | -$1.64K | ﹤0.01% | 2526 |
|
|
2019
Q4 | $2.08M | Buy |
873
+592
| +211% | +$16.3K | ﹤0.01% | 1446 |
|
|
2019
Q3 | $753K | Buy |
281
+139
| +98% | +$3.9K | ﹤0.01% | 2228 |
|
|
2019
Q2 | $385K | Sell |
142
-30
| -17% | -$941 | ﹤0.01% | 2834 |
|
|
2019
Q1 | $596K | Sell |
172
-769
| -82% | -$22.2K | ﹤0.01% | 2481 |
|
|
2018
Q4 | $1.84M | Buy |
941
+520
| +124% | +$10.7K | 0.01% | 1148 |
|
|
2018
Q3 | $1.12M | Buy |
421
+203
| +93% | +$6.63K | ﹤0.01% | 1774 |
|
|
2018
Q2 | $823K | Sell |
218
-21,513
| -99% | -$823K | ﹤0.01% | 1966 |
|
|
2018
Q1 | $719K | Buy |
21,731
+21,472
| +8,290% | +$942K | 0.03% | 532 |
|
|
2017
Q4 | $97K | Buy |
259
+196
| +311% | +$9.91K | ﹤0.01% | 1825 |
|
|
2017
Q3 | $53K | Sell |
63
-609
| -91% | -$35.8K | ﹤0.01% | 2261 |
|
|
2017
Q2 | $711K | Buy |
672
+442
| +192% | +$17.7K | 0.03% | 494 |
|
|
2017
Q1 | $108K | Sell |
230
-111
| -33% | -$3.54K | ﹤0.01% | 1681 |
|
|
2016
Q4 | $66K | Buy |
341
+25
| +8% | +$488 | ﹤0.01% | 1891 |
|
|
2016
Q3 | $56K | Buy |
+316
| New | +$7.42K | ﹤0.01% | 2010 |
|
|
2016
Q2 | – | Sell |
-57
| Closed | -$1K | – | 6738 |
|
|
2016
Q1 | $1K | Buy |
57
+31
| +119% | +$984 | ﹤0.01% | 5333 |
|
|
2015
Q4 | $13K | Buy |
26
+18
| +225% | +$873 | ﹤0.01% | 3110 |
|
|
2015
Q3 | $3K | Buy |
8
+1
| +14% | +$48 | ﹤0.01% | 4478 |
|
|
2015
Q2 | $5K | Buy |
7
+2
| +40% | +$80 | ﹤0.01% | 3718 |
|
|
2015
Q1 | $7K | Buy |
+5
| New | +$172 | ﹤0.01% | 3279 |
|
Simplex Trading's PTLA Position: Q3 2020 in Review
Simplex Trading sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 576 shares — an estimated $10K sold.
Simplex Trading first reported a position in PTLA in Q4 2014 and held it in 20 quarters. The position peaked at $1.3M in Q4 2019. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.
- Simplex Trading reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
- Simplex Trading sold 576 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $10K.
- Simplex Trading first reported a position in Portola Pharmaceuticals, Inc. in Q4 2014 and held it in 20 quarters.
- Simplex Trading's Portola Pharmaceuticals, Inc. position peaked at $1.3M in Q4 2019.
- 0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.
Based on Simplex Trading's 13F filing for Q3 2020, filed 14 Oct 2020.